Chapter 8 244 References American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Antonijevic, I. A., Murck, H., Frieboes, R. M., Uhr, M., & Steiger, A. (2003). On the role of menopause for sleep-endocrine alterations associated with major depression. Psychoneuroendocrinology, 28(3), 401-418. https://doi.org/10.1016/S0306-4530(02)00031-8 Bäckström, T., Haage, D., Löfgren, M., Johansson, I. M., Strömberg, J., Nyberg, S., Andréen, L., Ossewaarde, L., van Wingen, G. A., Turkmen, S., & Bengtsson, S. K. (2011). Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons. Neuroscience, 191, 46-54. https://doi.org/10.1016/j.neuroscience.2011. 03.061 Baglioni, C., Battagliese, G., Feige, B., Spiegelhalder, K., Nissen, C., Voderholzer, U., Lombardo, C., & Riemann, D. (2011). Insomnia as a predictor of depression: A meta-analytic evaluation of longitudinal epidemiological studies. Journal of Affective Disorders, 135(1-3), 10-19. https://doi.org/10.1016/j.jad.2011.01.011 Baker, F. C., & Driver, H. S. (2007). Circadian rhythms, sleep, and the menstrual cycle. Sleep Medicine, 8(6), 613-622. https://doi.org/10.1016/j.sleep.2006.09.011 Baker, F. C., Sassoon, S. A., Kahan, T., Palaniappan, L., Nicholas, C. L., TRINDER, J., & Colrain, I. M. (2012). Perceived poor sleep quality in the absence of polysomnographic sleep disturbance in women with severe premenstrual syndrome. Journal of Sleep Research, 21(5), 535-545. https://doi.org/10.1111/j.1365-2869.2012.01007.x Barrett-Connor, E., Dam, T. T., Stone, K., Harrison, S. L., Redline, S., & Orwoll, E. (2008). The association of testosterone levels with overall sleep quality, sleep architecture, and sleepdisordered breathing. Journal of Clinical Endocrinology and Metabolism, 93(7), 2602-2609. https://doi.org/10.1210/jc.2007-2622 Ben Dor, R., Harsh, V. L., Fortinsky, P., Koziol, D. E., Rubinow, D. R., & Schmidt, P. J. (2013). Effects of Pharmacologically Induced Hypogonadism on Mood and Behavior in Healthy Young Women. American Journal of Psychiatry, 170(4), 426-433. https://doi.org/10.1176/appi.ajp. 2012.12010117 Bloch, M., Daly, R. C., & Rubinow, D. R. (2003). Endocrine factors in the etiology of postpartum depression. Comprehensive Psychiatry, 44(3), 234-246. https://doi.org/10.1016/S0010440X(03)00034-8 Buddenberg, T. E., Komorowski, M., Ruocco, L. A., Silva, M. A. de S., & Topic, B. (2009). Attenuating effects of testosterone on depressive-like behavior in the forced swim test in healthy male rats. Brain Research Bulletin, 79(3-4), 182-186. https://doi.org/10.1016/ j.brainresbull.2009.02.008 Canady, V. A. (2019). FDA approves first drug for postpartum depression treatment. Mental Health Weekly, 29(12), 6-6. https://doi.org/10.1002/mhw.31830 Carrier, J., Land, S., Buysse, D. J., Kupfer, D. J., & Monk, T. H. (2001). The effects of age and gender on sleep EEG power spectral density in the middle years of life (ages 20-60 years old). Psychophysiology, 38(2), 232-242. https://doi.org/10.1111/1469-8986.3820232 Cohen, L. S., Soares, C. N., Vitonis, A. F., Otto, M. W., & Harlow, B. L. (2006). Risk for new onset of depression during the menopausal transition: The harvard study of moods and cycles. Archives of General Psychiatry, 63(4), 385-390. https://doi.org/10.1001/archpsyc.63.4.385 Cubała, W. J., Wiglusz, M., Burkiewicz, A., & Gałuszko-Węgielnik, M. (2010). Zolpidem pharmacokinetics and pharmacodynamics in metabolic interactions involving CYP3A: Sex as a differentiating factor. European Journal of Clinical Pharmacology, 66(9), 955. https://doi.org/10.1007/s00228-010-0854-x de Zambotti, M., Colrain, I. M., & Baker, F. C. (2015). Interaction between Reproductive Hormones and Physiological Sleep in Women. The Journal of Clinical Endocrinology & Metabolism, 100(4), 1426-1433. https://doi.org/10.1210/jc.2014-3892
RkJQdWJsaXNoZXIy MTk4NDMw